Can-Fite BioPharma Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 0.392 million compared to USD 0.409 million a year ago. Net loss was USD 4.22 million compared to USD 4.63 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 ILa | 0.00% | 0.00% | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 10.21M | |
-4.72% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- CANF Stock
- News Can-Fite BioPharma Ltd.
- Can-Fite BioPharma Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023